Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 14, 2022 | Seed | ¥200M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ruihua Venture Capital | — | Seed |